Page 1 of Clinical Trials for Drug fludarabine phosphate, 807 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma
Last Updated: February 6, 2009
Condition(s): Lymphoma
2
Recruiting
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Last Updated: April 18, 2012
Condition(s): Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma
3
Not yet recruiting
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
Last Updated: May 11, 2012
Condition(s): Leukemia; Lymphoma
4
Completed
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
Last Updated: January 26, 2010
Condition(s): Leukemia
5
Not yet recruiting
Crohn's Allogeneic Transplant Study
Last Updated: April 3, 2012
Condition(s): Crohn's Disease
6
Completed
Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer
Last Updated: July 23, 2008
Condition(s): Leukemia; Lymphoma
7
Not yet recruiting
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Last Updated: May 9, 2012
Condition(s): Myeloid Malignancy; Bone Marrow Failure Syndrome; Transfusion-dependent Red Blood Cell (RBC) Defect; Congenital Immunodeficiency; Metabolic Disease; Severe Immune Dysregulation
8
Recruiting
Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
Last Updated: September 23, 2011
Condition(s): Hematologic Malignancies; Nonmalignant Diseases; Immunodeficiencies; Hemoglobinopathies; Genetic Inborn Errors of Metabolism; Fanconi's Anemia,; Thalassemia; Sickle Cell Disease
9
Active, not recruiting
Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
Last Updated: February 6, 2009
Condition(s): Kidney Cancer
10
Recruiting
Fludarabine, Cyclophosphamide, and Rituximab Followed by Rituximab or Observation in Treating Older Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Last Updated: December 13, 2009
Condition(s): Leukemia
11
Completed
Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation
Last Updated: June 7, 2011
Condition(s): Hematologic Malignancies
12
Active, not recruiting
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant
Last Updated: July 15, 2011
Condition(s): Myelodysplastic and Myeloproliferative Disorders; Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders; Hematologic Diseases
13
Terminated
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
Last Updated: July 19, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of Childhood
14
Recruiting
Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
Last Updated: April 6, 2010
Condition(s): Leukemia
15
Recruiting
Fludarabine, Bendamustine, and Rituximab (FBR) in Chronic Lymphocytic Leukemia (CLL)
Last Updated: February 14, 2012
Condition(s): Leukemia
16
Completed
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
Last Updated: July 9, 2009
Condition(s): Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma; Allogeneic Marrow Transplant
17
Completed
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Last Updated: February 20, 2010
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Thrombocytopenia
18
Recruiting
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Last Updated: April 3, 2012
Condition(s): Nonmalignant Neoplasm
19
Recruiting
A Study to Determine the Efficacy of Lenalidomide Versus Investigator Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Last Updated: May 2, 2012
Condition(s): Mantle Cell Lymphoma; Relapsed or Refractory Mantle Cell Lymphoma
20
Recruiting
Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
Last Updated: August 12, 2011
Condition(s): Congenital Pediatric Disorders

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+fludarabine+phosphate

Page 1 of Clinical Trials for Drug fludarabine phosphate, 807 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About